Alexion Pharmaceuticals I... (ALXN)

AI Score

Unlock

182.50

0.00 (0.00%)

At close: Jan 01, 1970, 12:00 AM

Alexion Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	1.64B	1.59B	1.59B	1.44B	1.44B	1.38B	1.26B	1.2B	1.14B	1.13B	1.03B	1.04B	930.9M	910.1M	859M	912M	870M	830.74M	799.11M	753.12M	701.04M
Cost of Revenue	125.4M	152.2M	144.7M	144.9M	111.7M	114.3M	95.2M	99.2M	85.8M	96.8M	90.6M	95.3M	91.6M	144.2M	157M	84M	69M	67.29M	71.09M	60.63M	58.99M
Gross Profit	1.51B	1.44B	1.44B	1.3B	1.33B	1.27B	1.17B	1.1B	1.05B	1.03B	935.9M	949.7M	839.3M	765.9M	702M	828M	801M	763.45M	728.01M	692.49M	642.05M
Operating Income	636.2M	647M	770.8M	703.5M	738.6M	545.5M	560.1M	537.1M	497.2M	427.7M	422.4M	418.9M	325.6M	124M	156M	284M	240M	218.41M	220.16M	201.32M	153.11M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	602.6M	590.6M	666.9M	-1.35B	663.6M	602M	535.5M	499.5M	541.8M	-32.9M	342.1M	-418.6M	351.6M	89.8M	58M	206M	194M	104.32M	158.11M	169.97M	143.6M
Net Income	636M	535.8M	578.1M	-1.07B	557.6M	889M	467.6M	459.8M	587.9M	-45M	330.9M	-457.4M	249.1M	30.3M	78M	165M	170M	92.44M	94.34M	114.94M	92.17M
Selling & General & Admin	342.9M	444.4M	334.2M	301.4M	319.9M	381M	299.3M	299.3M	281.5M	318.7M	258.7M	277.3M	257.1M	296.4M	271M	265M	262M	259.51M	230.13M	231.8M	232.56M
Research & Development	289.1M	295M	285.9M	221.1M	200.9M	269.6M	232.9M	187.6M	195.9M	205.6M	174.8M	173.4M	176.6M	265.4M	195M	199M	219M	205.71M	195.69M	179.31M	176.29M
Other Expenses	53.2M	53.2M	53.1M	73.7M	73.7M	73.9M	75.6M	80.1M	80M	80M	80M	80.1M	80M	80.1M	80M	80M	80M	79.81M	82.04M	80.06M	80.09M
Operating Expenses	685.2M	792.6M	673.2M	596.2M	594.5M	724.5M	607.8M	567M	557.4M	604.3M	513.5M	530.8M	513.7M	641.9M	546M	544M	561M	545.04M	507.85M	491.17M	488.94M
Interest Expense	27.1M	27.7M	27.6M	23.6M	25.8M	21.7M	17.9M	18.3M	19.9M	24.5M	24.6M	25M	24.1M	25.4M	25M	24M	24M	24.51M	24.81M	23.79M	23.89M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	810.6M	944.8M	817.9M	741.1M	706.2M	838.8M	703M	666.2M	643.2M	701.1M	604.1M	626.1M	605.3M	786.1M	703M	628M	630M	612.33M	578.95M	551.79M	547.93M
Income Tax Expense	113.4M	54.8M	88.8M	-284M	106M	-287M	67.9M	39.7M	-46.1M	12.1M	11.2M	38.8M	102.5M	59.5M	-20M	41M	24M	11.89M	63.78M	55.02M	51.43M
Shares Outstanding (Basic)	220.1M	219.1M	219.1M	220.6M	221.6M	221.3M	223.3M	224.2M	223.8M	223.2M	222.9M	222.6M	222.1M	223.3M	223M	224M	224M	225M	224.18M	224.09M	225.06M
Shares Outstanding (Diluted)	222.6M	219.1M	220.6M	220.6M	222.6M	222.5M	224.5M	225.6M	225.5M	223.2M	224.6M	222.6M	223.7M	225M	225M	225M	226M	226M	226.09M	225.76M	226.87M
EPS (Basic)	2.89	2.45	2.64	-4.84	2.52	4.02	2.09	2.05	2.63	-0.2	1.48	-2.05	1.12	0.14	0.35	0.74	0.76	0.41	0.42	0.51	0.41
EPS (Diluted)	2.86	2.45	2.62	-4.84	2.50	4.00	2.08	2.04	2.61	-0.2	1.47	-2.05	1.11	0.13	0.35	0.73	0.75	0.41	0.42	0.51	0.41
EBITDA	852.1M	693.4M	769.7M	-1.24B	778.7M	714.3M	645.9M	614.3M	658.9M	90M	471.6M	-293.1M	477.2M	300.9M	193M	332M	317M	229.57M	283.6M	291.55M	264.27M
EBIT	629.7M	618.3M	694.5M	-1.33B	689.4M	623.7M	553.4M	517.8M	561.7M	-8.4M	366.7M	-393.6M	375.7M	115.2M	83M	230M	218M	128.83M	182.92M	193.76M	167.49M
Depreciation & Amortization	75.6M	75.1M	75.2M	89.8M	89.3M	90.6M	92.5M	96.5M	97.2M	98.4M	104.9M	100.5M	101.5M	185.7M	110M	102M	99M	100.74M	100.68M	97.8M	96.78M